The Bad Side Effects of Semaglutide — and What to Do About Them

GI side effects are the most frequently reported and are usually most pronounced in the first two to four weeks of each new dose.
Pancreatitis is rare but serious: the MHRA issued a formal Drug Safety Update in January 2026 highlighting persistent severe stomach pain as a prompt for urgent medical attention.
Yellow Card reporting lets patients flag any suspected side effect directly to the MHRA at yellowcard.mhra.gov.uk.
A prescriber reviews your health history at every stage (starting treatment, dose changes, and repeats) so concerns can be raised before they become problems.

The most common bad side effects of semaglutide are gastrointestinal: nausea, vomiting, diarrhoea, and constipation affect a significant proportion of people starting treatment, particularly in the first few weeks or after a dose increase. They're uncomfortable, but for most people they ease as the body adjusts. Semaglutide (sold as Wegovy for weight management) is a prescription-only medicine; a GPhC-registered prescriber assesses your full medical picture before any treatment is issued, including whether these effects are likely to be a problem for you specifically.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

A practical walkthrough: what to expect, what to watch, and when to act

Step 1 — Recognise what's common (and why it happens)

Semaglutide slows the speed at which your stomach empties. That's useful for appetite control, but it's also the reason your digestive system objects at first. Nausea is the most reported complaint; vomiting, loose stools, constipation, acid reflux, and burping follow closely behind. The NHS semaglutide page lists these explicitly and confirms they are most common when you begin treatment or move to a higher dose.

Fatigue and headache show up too, often in the same early window. These aren't signs something is wrong with the medicine, they're signs your body is recalibrating. Small, low-fat meals, eating slowly, and staying well-hydrated reduce the severity for most people. If you want a quick self-check you can do right now, scan back over the past 24 hours: if you've skipped meals because of nausea and had very little fluid, that's the pattern most likely to tip discomfort into something worse.

For a fuller breakdown of how each effect tends to behave over time, the semaglutide side effects guide goes into more depth on frequency and duration. What matters here is that common doesn't mean trivial, it means manageable, with the right support.

Step 2, Know which effects are less common but more serious

Rarer effects deserve a sharper look. Pancreatitis (inflammation of the pancreas) is infrequent, but in January 2026 the MHRA issued a Drug Safety Update specifically about GLP-1 medicines and this risk. The signal is a severe, persistent stomach pain that may radiate into the back, sometimes alongside vomiting. That pattern is different from ordinary nausea and needs same-day medical attention, not a paracetamol and a lie-down.

Gallbladder problems can surface too: right-sided or upper abdominal pain, particularly after eating, may point to gallstones, which are more common with rapid weight loss. Severe dehydration from prolonged vomiting or diarrhoea puts strain on the kidneys; if you're unable to keep fluids down for more than a day, that's a reason to call 111 or your GP rather than wait it out.

Mood changes, including low mood or, rarely, thoughts of self-harm, have been reported with GLP-1 medicines. This is listed in the product information and is worth knowing about before you start. It doesn't mean it will happen, but it does mean you should mention any changes in your mental state to your prescriber promptly. A detailed look at the more serious side effects of Wegovy covers these and the steps to take.

Step 3, Act on red flags without delay

There is a short list of symptoms that should prompt you to stop treatment and seek medical help the same day. The MHRA's guidance, reflected in the product leaflet, identifies: severe and persistent abdominal pain (pancreatitis signal); signs of a serious allergic reaction such as swelling of the face or throat, difficulty breathing, or a spreading rash; sudden changes in vision; and symptoms of serious dehydration, extreme thirst, very dark urine, dizziness on standing.

If you're unsure whether what you're experiencing is on that list, calling 111 is a reasonable first step. For anything suggesting anaphylaxis, call 999. The Yellow Card scheme at yellowcard.mhra.gov.uk exists specifically so patients can report suspected side effects directly to the MHRA, it takes about five minutes and helps build the national safety picture for everyone on these medicines.

At nume, every repeat order is reviewed by a prescriber before it is approved, there are no automatic refills. That's a deliberate safeguard, not a friction point. If a side effect has changed your picture since your last order, our clinical team will pick it up. You can also reach our aftercare team seven days a week between orders.

Step 4, Put side effects in context of your clinical review

Starting semaglutide for weight management is a clinical decision, not a transaction. The Wegovy overview sets out the full scope of what the treatment involves, including the dose escalation pathway that is specifically designed to reduce the severity of early side effects. Titration exists for a reason: beginning at a lower dose and moving up gradually gives your body time to adjust, and a prescriber paces that based on how you're tolerating each stage.

The cardiovascular data for semaglutide (including how it affects risk beyond weight loss) is covered separately if you're interested in how semaglutide reduces cardiovascular risk. If you'd like to understand what a side effect of semaglutide looks like in practice, and how it differs from a warning sign that needs medical attention, that page walks through the distinction clearly. Semaglutide is not recommended during pregnancy, while breastfeeding, or for anyone trying to conceive; it isn't licensed for under-18s. People with a history of pancreatitis or certain gastrointestinal conditions need to discuss those with a prescriber before starting.

If you'd like to talk through your specific history and whether semaglutide is appropriate for you, speak to our prescribers through the free consultation. Our clinical team (you can read more about our approach on the clinical team page) reviews suitability and the side effects from semaglutide that are most relevant to your health profile as a standard part of every assessment.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions